The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients

The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients

(1) Background: Multiple sclerosis (MS) is a biologically highly heterogeneous disease and has poor predictability at diagnosis. Moreover, robust data indicate that early disease activity strongly correlates with future disability. Therefore, there is a need for strong and reliable biomarkers from d...

Full description

Saved in:
Bibliographic Details
Main Authors: Eleonora Virgilio, Chiara Puricelli, Nausicaa Clemente, Valentina Ciampana, Ylenia Imperatore, Simona Perga, Sveva Stangalini, Elena Boggio, Alice Appiani, Casimiro Luca Gigliotti, Umberto Dianzani, Cristoforo Comi, Domizia Vecchio
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Neurology International
Subjects:
multiple sclerosis
biomarker
osteopontin
neurofilament
neurodegeneration
tau
Online Access:https://www.mdpi.com/2035-8377/17/7/110
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2035-8377/17/7/110

Similar Items